•
Publications & Policy•
Publications•
Response to the European Commission Call for Evidence on the European Biotech Act
Positions & consultation responses
Invest Europe’s response highlights the need to close Europe’s biotech commercialization gap by accelerating time to market for breakthrough innovations, bridging the biotech investment gap, unlocking the potential of data, AI and quantum computing, and strengthening Europe’s entrepreneurial workforce.
EU venture capital programme a ‘great step forward’, says Invest Europe
Press releases
10 Apr 2018
Response to the European Commission Consultation on the EU life sciences strategy
Positions & consultation responses
16 Apr 2025
Position Paper on Investment Omnibus proposal
Positions & consultation responses
18 Mar 2025
Response to EC Consultation on General Block Exemption Rule
Positions & consultation responses
09 Dec 2021
Letter to the European Commission on public support to SMEs backed by private equity
Positions & consultation responses
01 Apr 2020
Position paper on EU response to the US Inflation Reduction Act
Positions & consultation responses
16 Mar 2023
Response to the European Commission’s targeted survey on simplifying the General Block Exemption Regulation (GBER)
Positions & consultation responses
02 Jul 2026
Position on the draft 2027-2034 General Block Exemption Regulation (GBER)
Positions & consultation responses
17 Apr 2026
Response to the European Commission Consultation on the Draft Merger Guidelines
Positions & consultation responses
26 Jun 2026
EVCA-PAE Response to Green Paper on Capital Markets Union
Positions & consultation responses
13 May 2015
EC Green Paper on Capital Markets Union
Positions & consultation responses
18 Feb 2015
Invest Europe CEO letter to EU Heads of State - Europe’s Moment of Decision
Positions & consultation responses
19 Mar 2026